Atrial Sensing Capability for Better Detection of Atrial Fibrillation

  • End date
    May 31, 2023
  • participants needed
  • sponsor
    Samsung Medical Center
Updated on 10 October 2021
implantable cardioverter-defibrillators


This prospective multi-center randomized controlled study aims to compare atrial fibrillation detection and inappropriate therapy according to activation of atrial sensing capability in patients with implantable cardioverter defibrillator.


Implantable cardioverter defibrillators(ICD) therapy has been shown to reduce sudden cardiac death and improve survival in cardiac arrest survivors as well as in heart failure patients with left ventricular dysfunction.

Atrial fibrillation (AF) is commonly found in ICD implantation patients up to 50%. AF is an independent predictor of mortality, inappropriate shock, and embolic events. Therefore, early detection of AF in patients with ICD is essential for improving the quality of life and overall prognosis of the patients.

Conventional ICDs consist of a single chamber (SC) ICD with a lead only in the right ventricle (RV) and dual chamber (DC) ICD with each lead in the right atrium (RA) and RV. SC ICD has the advantage of shorter procedure time, lower cost compared to DC ICD. In contrast, DC ICD has the advantage of being able to monitor atrial arrhythmic events, but complication rates were higher and additional cost and longer procedure time are usually required than SC ICD. Sixty percent of ICD implantation patients who have are SC ICD Recently, a unique ICD lead with atrial sensing ring capable of monitoring the atrial electrical signals has been developed [Intica 7 VR-T DX ICD (Biotronik., Germany)]. Therefore, turning off the atrial sensing function makes it functionally the same as SC ICD whereas turning on makes it function similar to DC ICD without additional cost and procedure time.

Therefore, Detection of AF could be made earlier with VDD ICD versus conventional SC ICD without atrial sensing capability, providing a better chance to improve the prognosis of ICD patients. However, no study exists which shows whether VDD ICD is better for detecting atrial tachyarrhythmia than conventional SC ICD. Therefore, we designed a multicenter prospective randomized study comparing the AF diagnostic efficacy of VDD ICD (with atrial sensing 'ON') against conventional SC ICD. As the second phase, we also plan to compare inappropriate therapy rate according to atrial sensing status of VDD ICD.

Condition Implantable defibrillator, dysrhythmias, Arrhythmia, Heart Disease, Heart disease, abnormal heart rhythms, Atrial Fibrillation (Pediatric), Cardiac Event, arrhythmias, Cardiac Disease, cardiac events, cardiac arrhythmias, implantable cardioverter-defibrillators, implantable cardioverter defibrillator, cardiac arrhythmia, Dysrhythmia, Atrial Fibrillation, cardiac dysrhythmias
Treatment Atrial sensing On mode
Clinical Study IdentifierNCT03932604
SponsorSamsung Medical Center
Last Modified on10 October 2021


Yes No Not Sure

Inclusion Criteria

age 19 years
indication for ICD implantation according to guidelines
atrial fibrillation didn't detect by electrocardiogram or Holter test within the past 1 year from the ICD implantation, and
CHA2DS2VASc score 1 point in male or 2 in female

Exclusion Criteria

persistent or permanent atrial fibrillation (AF)
atrial fibrillation detected by electrocardiogram or Holter test within the past 1 year from the ICD implantation
history of the catheter or surgical ablation of AF or taking antiarrhythmic drug
scheduled to undergo heart transplant within 1 year
life expectancy < 1 year
requiring atrial pacing
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note